Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
111 studies found for:    Fabry Disease
Show Display Options
Rank Status Study
21 Completed Vasodilation in Patients With Fabry's Disease
Conditions: Cerebrovascular Accident;   Fabry Disease;   Healthy
Intervention:
22 Enrolling by invitation Fabry's Disease and Pregnancy (PREFAB)
Conditions: Fabry's Disease;   Pregnancy
Intervention: Other: Questionnaire
23 Recruiting Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
24 Completed PET Scans in Normal Volunteers and Patients With Fabry Disease
Conditions: Fabry Disease;   Healthy
Intervention:
25 Completed Alpha-Galactosidase A Replacement Therapy for Fabry Disease
Condition: Fabry Disease
Intervention: Drug: DRX005B
26 Unknown  Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease
Condition: Fabry Disease
Intervention:
27 Completed Data Collection in Women With Fabry Disease
Condition: Fabry Disease
Intervention:
28 Completed An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
29 Recruiting Evaluation of the Gastrointestinal Manifestation of Fabry's Disease
Condition: Fabry's Disease
Interventions: Device: Smartpill;   Procedure: Endoscopic Mucosal Resection and Sigmoidoscopy
30 Completed
Has Results
Dosing Study of Replagal in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
31 Active, not recruiting Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: migalastat HCl 150 mg
32 Completed Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
Condition: Fabry Disease
Intervention:
33 Completed Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal (Agalsidase Alfa);   Drug: Replagal
34 Recruiting Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: Lentivirus Alpha-gal A transduced stem cells
35 Completed Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
36 Recruiting Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
Conditions: Fabry Disease;   Cerebrovascular Accident
Intervention: Other: No intervention
37 Unknown  Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers
Conditions: Fabry Disease, Cardiac Variant;   Right Ventricular Hypertrophy
Intervention:
38 Unknown  Viennese Prevalence Study of Anderson-Fabry Disease
Conditions: Fabry Disease;   Left Ventricular Hypertrophy
Intervention:
39 Completed Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
Condition: Fabry Disease
Intervention: Drug: AT1001
40 Recruiting Physician Initiated Request for Migalastat in Individual Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: migalastat HCl

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years